Nuclear factor-erythroid-2-related factor 2 in aging and lung fibrosis
(PubMed) Regulatory reports: the FDA (USA) highlighted multiple adverse events linked to compounded glutathione injections from mild to severe and life-threatening
Some discontinued clinical trials (for example in postoperative ileus) failed to demonstrate sufficient efficacy in primary endpoints, although certain biological signaling effects remained measurable and scientifically relevant
Huang, Y., Kim, S.-O., Yang, N., Jiang, J
The GST-fusion protein first binds to glutathione agarose, and then after other contaminating proteins have been washed away, reduced glutathione is added to elute the GST-fusion protein from the resin (Figure 5)